Metformin with insulin relieves oxidative stress and confers renoprotection in type 1 diabetes in vivo

Christine Driver, Julia Achieng Hayangah, Ntsoaki Annah Nyane, Peter Mark Oroma Owira *

Cited by CrossRef: 5

1- Yarube I, Ayo J, Magaji R, Umar I. Insulin treatment increases brain nitric oxide and oxidative stress, but does not affect memory function in mice. Physiology & Behavior. 2019;211:112640 [Crossref]

2- Ghiasi B, Sarokhani D, Najafi F, Motedayen M, Dehkordi A. The Relationship Between Prostate Cancer and Metformin Consumption: A Systematic Review and Meta-analysis Study. CPD. 2019;25(9):1021 [Crossref]

3- Malaekeh-Nikouei A, Shokri-Naei S, Karbasforoushan S, Bahari H, Baradaran Rahimi V, Heidari R, Askari V. Metformin beyond an anti-diabetic agent: A comprehensive and mechanistic review on its effects against natural and chemical toxins. Biomedicine & Pharmacotherapy. 2023;165:115263 [Crossref]

4- Maji D, Samanta S, Patil V. In Silico ADMET and Docking Studies of Thiazolidinedione-acetic-acid Hybrids as Antidiabetics with Cardioprotection. LDDD. 2020;17(12):1475 [Crossref]

5- Hasanvand A. The role of AMPK-dependent pathways in cellular and molecular mechanisms of metformin: a new perspective for treatment and prevention of diseases. Inflammopharmacol. 2022;30(3):775 [Crossref]